Prevision Medicine tests living tumour cells from patients against a large library of treatments to guide therapy choice in oncology. The Zurich-based company has closed a USD 5.4 million seed round, led by ACE Ventures, to obtain approvals and reimbursement and expand in Europe.
- Announced on
- Round
- Seed
- Amount
- USD 5.4 M
- Location
- Zurich
Investors
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic